BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24037346)

  • 21. Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma.
    Mao J; Yin H; Wang L; Wu JZ; Xia Y; Zhu HY; Fan L; Li JY; Liang JH; Xu W
    Ann Hematol; 2021 Feb; 100(2):445-453. PubMed ID: 33140135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased body mass index is associated with improved overall survival in extranodal natural killer/T-cell lymphoma, nasal type.
    Li YJ; Yi PY; Li JW; Liu XL; Liu XY; Zhou F; OuYang Z; Sun ZY; Huang LJ; He JQ; Yao Y; Fan Z; Tang T; Jiang WQ
    Oncotarget; 2017 Jan; 8(3):4245-4256. PubMed ID: 28002803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.
    Yhim HY; Kim JS; Mun YC; Moon JH; Chae YS; Park Y; Jo JC; Kim SJ; Yoon DH; Cheong JW; Kwak JY; Lee JJ; Kim WS; Suh C; Yang DH;
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1597-604. PubMed ID: 25963920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical characteristics and prognostic analysis of advanced-stage extranodal NK/T cell lymphoma].
    Wei C; Zhang Y; Wang W; Zhang L; Zhang W; Zhou DB
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):462-468. PubMed ID: 32654458
    [No Abstract]   [Full Text] [Related]  

  • 25. The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma.
    Li N; Jiang M; Wu WC; Zou LQ
    Ann Hematol; 2022 Jul; 101(7):1545-1556. PubMed ID: 35635579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients.
    Kim SJ; Ryu KJ; Hong M; Ko YH; Kim WS
    J Hematol Oncol; 2015 May; 8():49. PubMed ID: 25966773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic evaluation of the prognostic value of
    Xu P; Guo R; You J; Cheng S; Li J; Zhong H; Sun C; Xu H; Huang H; Li B; Zhao W
    Ann Hematol; 2021 Apr; 100(4):1039-1047. PubMed ID: 33634350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretreatment 14-3-3 epsilon level is predictive for advanced extranodal NK/T cell lymphoma therapeutic response to asparaginase-based chemotherapy.
    Qiu Y; Zhou Z; Li Z; Lu L; Li L; Li X; Wang X; Zhang M
    Proteomics Clin Appl; 2017 Mar; 11(3-4):. PubMed ID: 27774748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of TIM-3 and LAG-3 in extranodal NK/T cell lymphoma, nasal type.
    Feng Y; Zhong M; Liu Y; Wang L; Tang Y
    Histol Histopathol; 2018 Mar; 33(3):307-315. PubMed ID: 28901003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
    Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
    Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal type.
    Dai W; Jia B; Yang J; Zhou S; Liu P; He X; Qin Y; Gui L; Zhang C; Han X; Sun Y; Shi Y
    Oncotarget; 2017 May; 8(21):34787-34795. PubMed ID: 28410236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma.
    Wang L; Xia ZJ; Lu Y; Wang QX; Niu SQ; Huang HQ; Zhang YJ
    Leuk Lymphoma; 2015; 56(11):3038-44. PubMed ID: 25747971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
    Wang H; Li P; Zhang X; Xia Z; Lu Y; Huang H
    Oncol Lett; 2016 Aug; 12(2):825-836. PubMed ID: 27446357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A proposal for a prognostic index for non-nasal type natural killer/T cell lymphoma after asparaginase-based treatment.
    Chen Z; Fang X; Huang H; Wang Z; Hong H; Chen M; Ren Q; Yao Y; Zhang L; Tian Y; Lin S; Lin T
    Ann Hematol; 2020 Dec; 99(12):2811-2819. PubMed ID: 32975588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal type.
    Wei L; Wang L; Cong J; Yang L; Ye J; Li X; Yao N; Yang J; Wang J
    Leuk Res; 2020 Sep; 96():106422. PubMed ID: 32721642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type.
    Jiang L; Li P; Wang H; Liu J; Zhang X; Qiu H; Zhang B
    Med Oncol; 2014 Oct; 31(10):218. PubMed ID: 25204411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients.
    Wang H; Wang L; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Li ZM; Lu Y
    Oncotarget; 2016 May; 7(22):33035-45. PubMed ID: 27105512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.
    Wang H; Li P; Wang L; Xia Z; Huang H; Lu Y; Li Z
    Ann Hematol; 2015 Sep; 94(9):1535-44. PubMed ID: 25990795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended Course and Increased Dose of Initial Chemotherapy for Extranodal Nasal Type Natural Killer/T (NK/T)-Cell Lymphoma in Patients <60 Years Old: A Single-Center Retrospective Cohort Study.
    Xu Y; Wang J; Zhang W; Liu J; Cao X; He A; Chen Y; Gu L; Lei B; Zhang P; Ma X
    Med Sci Monit; 2016 Nov; 22():4297-4311. PubMed ID: 27843135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus infection correlates with poor prognosis of extranodal natural killer/T cell lymphoma.
    Wang L; Wu-Xiao ZJ; Chen XQ; Zhang YJ; Lu Y; Xia ZJ
    Leuk Lymphoma; 2015 Apr; 56(4):936-41. PubMed ID: 25110821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.